We can’t show the full text here under this license.
Abstract
(MASLD) is strongly associated with (CVD).
- There is an increasing prevalence of MASLD globally.
- Different terminologies for fatty liver disease may affect cardiovascular risk assessment.
- Pathophysiological mechanisms connecting MASLD and CVD are explored.
- MASLD may influence traditional cardiovascular risk factors.
- Noninvasive imaging techniques and biomarkers are relevant for assessing cardiovascular risk in MASLD patients.
- The review provides insights into clinical management and prevention strategies related to MASLD and CVD.
Simplified